2. Definition
Skin substitutes are heterogeneous group of wound
coverage materials that aid in wound closure and replace
the functions of the skin, either temporarily or
permanently, depending on the product characteristics.
These substances are alternatives to the standard wound
coverage in circumstances when standard therapies are
not desirable
3. Introduction
The need for supplements to autologous skin grafts has
prompted development and use of wide variety of skin
substitutes as biologic and synthetic wound dressings
Functions:
Permanent wound coverage
Temporary coverage to promote healthy wound bed
4. Ideal Skin Substitutes
little or no antigenicity
tissue compatibility
lack of toxicity, either local or systemic
permeability to water vapor just like normal skin
impenetrability to microorganisms
rapid and persistent adherence to a wound surface
porosity for ingrowth of fibrovascular tissue from the
wound bed
Able to resist infection
5. Able to prevent water loss
Able to withstand the shear forces
Cost effective
Widely available
Long shelf life and easy to store
Flexible in thickness
Durable with long-term wound stability
Can be conformed to irregular wound surfaces and
Easy to be secured and applied
6. Classification (Kumar P, 2008)
Class I: Temporary impervious dressing materials
a) single layer materials
naturally occurring or biological dressing substitute, e.g. amniotic
membrane, potato peel
synthetic dressing substitute, e.g. synthetic polymer sheet
(Tegaderm®, Opsite®), polymer foam or spray
b) bi-layered tissue engineered materials, e.g. TransCyte®
7. Class II: Single layer durable skin substitutes
Epidermal substitutes, e.g. cultured epithelial autograft (CEA),
Apligraf®
Dermal substuitutes
bovine collagen sheet, e.g. Kollagen®
porcine collagen sheet
bovine dermal matrix, e.g. Matriderm®
human dermal matrix, e.g. Alloderm®
8. Class III: Composite skin substitutes (containing both
dermal and epidermal component)
a) Skin graft
Allograft
Xenograft
b) Tissue engineered skin
Dermal regeneration template, e.g. Integra®
Biobrane®
9.
10. Use of Bioactive Skin Substitutes
Wound cover
Improve wound healing
Control pain
Improve functional and cosmetic outcome
Increase survival
12. Xenografts
Earliest In 1500 BC
Homogenised cryopreserved porcine xenograft
recent modifications to the porcine skin include aldehyde
cross-linking and silver ion impregnation to increase the
antimicrobial properties
13. Advantages:
Low cost
Reduces pain
Decreased fluid loss
Good wound adherence
Disadvantages:
Lack of revascularisation
Lack of transparency
15. Uses:
Wound bed preparation
provide growth factors and essential cytokines
creating chemotaxis and proliferation at wound beds.
increase vascularity in the wound bed
promoting angiogenesis with enhanced capillary ingrowth on the wound bed
Pain free dressings
Sandwich grafting technique
prevents desiccation of the wound bed in the interstices of widely expanded
autografts
reduces bacterial colonisation
autograft is protected from shear
16. Advantages :
Provide biologically active temporary wound cover
Decrease metabolic demands
Provide a ‘test’ to assess whether wound is ready for
autograft
Disadvantages:
Expensive
Risk of disease transmission
Need for further procedure for wound closure
17. Amnion
thin semi-transparent tissue forming the innermost layer
of the foetal membrane
Advantages:
maintains low bacteria count
reduces loss of protein, electrolytes and fluids, decreasing the
risk infection
minimises pain
acceleration of wound healing
good handling properties.
18. Synthetic Skin substitutes
Advantages:
composition and properties of the product can be much more
precisely controlled
avoid complications due to potential disease transmission
Disadvantages:
lack basement membrane
their architecture do not resemble native skin
19. Biobrane®
Composed of bilaminated membrane formed by nylon
mesh filled with Type I porcine collagen (dermal analogue)
and covered by a thin membrane of silicon (epidermal
analogue)
20. Indications:
Superficial partial thickness burn wounds
Donor sites
TENS patients
Contraindications:
Full thickness burns
Patial thickness burn with eschar
Chemical or electrical burns
21. Advantages:
Pliability and elasticisity
Confirms to irregular wounds
Good pain control
Less frequent dressing change
Extended shelf life
Transparent dressing for wound monitoring
22. Transcyte®
Temporary
Dermal layer of neonatal fibroblasts on a nylon mesh and
outer layer of synthetic epidermis
Contains :
Collagen type III, V
Fibronectin and tenascin
GAGs
GF : TGF-B1, VEGF, IGF-1
23. Similar to biobrane but with addition of growth factors
from lysed fibroblasts grown in culture
24. Semipermeable to allow fluid and gas exchange
Transparent for monitoring
Used as substitute for cadaveric allograft in full thickness
burns after excision
26. Integra® (Yannas et al, 1980)
Dermal analog made of cross linked bovine collagen-
GAG (chondroitin -6- sulphate) copolymer matrix
Epidermal analog thin silicone elastomer
After dermal analog incorporates (2-3 wks), silicon layer
is removed and replaced by thin SSG or Epicel
27.
28. Advantages:
Regenerated skin is more pliable
Resembles normal skin
Favourable scarring
Provides physiologic wound closure
Disadvantages:
Costly
2 stage procedure with 3-4 week interval
29. Uses:
Scar contracture release
Excision of Giant congenital naevus
Irradiated scalp chronic wound closure
Exposed bone and tendons
30. Apligraf®
Permanent bilayered skin substitute
Dermal layer: Type I bovine collagen and allogenic
keratinocyte seeded with human foetal fibroblasts
31. Advantages:
Readily available
Applied in OPD setting
Disadvantages
Remote risk of disease transmission
Multiple applications
Short shelf life (5 days)
Expensive
Uses:
Diabetic ulcers
Venous stasis ulcers
Epidermolysis Bullosa.
32. Alloderm®
Scar Contracture is inversely related to the amount of
dermis
Treated human allograft with epidermis removed
resulting in intact BM and Collagen and removal of
antigenic Langerhans cells, melanocytes and fibroblasts
Used as dermal implant
Thin epithelial autograft is required
34. Dermagraft®
A cryopreserved human fibroblast derived dermal
substitute made of bioabsorbable polyglactin mesh
(bioabsorbable scaffold) seeded with allogenic neonatal
fibroblasts
Dermagraft human fibroblasts which secrete growth
factors, cytokine, ECM proteins and GAGs
Formation of neodermis through stimulation of
fibrovascular growth from wound bed and not by direct
re epithelialization from wound perimeter
35. Indications
chronic wounds and diabetic foot ulcers
to support the take of meshed split-thickness skin grafts on
excised burn wounds
36. OrCel®
Bilayered cellular matrix in which normal human
allogeneic skin cells (epidermal keratinocytes and dermal
fibroblasts) are cultured in two separate layers into a
type I bovine collagen sponge.
Indication:
treatment of chronic wounds
skin graft donor sites
as an overlay dressing on split-thickness skin grafts to improve
function and cosmesis
37. Cultured Epithelial Autografts
Epicel®
Rhinewald and Green (1975)
The autologous keratinocytes are isolated, cultured and
expanded into sheets over periods of 3–5 weeks. The
technique of suspension in fibrin glue has reduced the
time for clinical use to 2 weeks.
Uses:
Coverage of large TBSA wounds
Coverage of giant congenital naevus wound
Pressure ulcers
Vitiligo
38. Advantages:
avoids the mesh aspect of split skin autografts
avoids discomfort of donor site after skin harvesting.
Disadvantages:
fragility and difficulty of handling
Shearing and blistering
unpredictable take rate
high cost.
39.
40.
41.
42. Conclusion
Skin substitutes have a important role to play in plastic
surgery in complex wound management for cutaneous
continuity
Only a bridge until wound is better suited to accept graft
Prohibitive costs and availability limit the usage to
research settings
Future prospects
To date, there is no ideal skin substitute available that fulfills all the above-mentioned features. Currently, tissue engineering and biotechnology are gearing towards the direction of creating an optimal skin substitute.